AMANDA DILL: Open Payments
NPI 1427445683 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 11 payments from 5 companies in 2025. Trend: 2023 $639 · 2024 $467 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $168 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: DUPIXENT, NUCALA, NEFFY, Rhapsido, TEZSPIRE.
Industry payments across TN — which companies pay providers there.
